Not Tagged
TORL BioTherapeutics
[]
looking forward to torl biotherapeutics announcing the initial results of novel claudin 6 (cldn6) targeted antibody drug conjugate (adc) torl-1-23. we look forward to opening these studies in the trio-us network! 
Translational Research In Oncology-US, A Site Management Organization with 14+ sites and access to 200+ Investigators interested in clinical research.